CONFIDENTIAL — APPROVED FOR PUBLIC RELEASE · BUREAU FILE COPY RECORDS CURRENT AS OF 29 MAY 2026 · DISTRIBUTION: UNRESTRICTED
VendorInvestigator Independent Testing Bureau · Public Records Division
DOCKET YEAR 2026 · VOL. II
35,156 SAMPLES ON FILE
No fee · No favor
Compound Evidence File
#EC-2026-0768

Tren Hex Raw

Filed under Raw Materials. The bureau holds 114 laboratory returns for this compound from 34 distinct subjects. Scores below are per-subject aggregates; open a subject row for the underlying evidence.

Cross-Index

Subjects Shipping This Compound

34 SUBJECTS
SubjectGradeSamplesMeanMinMaxFirst seenLast seen
Tianjin Finder Chemical TFCCASE #VI-2026-0693 A 5 10.0 9.9 10.0 14 Nov 2025 16 Apr 2026
Kerui PeptidesCASE #VI-2026-0626 A 4 10.0 9.9 10.0 10 Apr 2026 5 May 2026
Chinese Peptide CompanyCASE #VI-2026-0184 A 4 10.0 10.0 10.0 15 Dec 2025 13 May 2026
WuXi TIDESCASE #VI-2026-0335 A 4 10.0 9.9 10.0 10 Mar 2026 15 Jun 2026
AsymchemCASE #VI-2026-0091 A 4 10.0 9.9 10.0 13 May 2026 7 Jul 2026
Shanghai ERP BiotechnologyCASE #VI-2026-0936 A 3 10.0 9.9 10.0 19 Jan 2026 6 May 2026
Sangon BioCASE #VI-2026-0671 A 3 10.0 9.9 10.0 10 Nov 2025 1 Jul 2026
QYAOBIOCASE #VI-2026-0861 A 3 10.0 10.0 10.0 11 Apr 2026 9 Jun 2026
Hubei JianxiangCASE #VI-2026-0048 A 3 10.0 9.9 10.0 4 Mar 2026 4 Jul 2026
GenScript PeptidesCASE #VI-2026-0860 A 3 10.0 10.0 10.0 10 Jul 2026 3 Aug 2026
JEEP PeptidesCASE #VI-2026-0457 A 2 10.0 10.0 10.0 24 Mar 2026 10 May 2026
Mokemei BiotechnologyCASE #VI-2026-0540 A 2 10.0 10.0 10.0 26 Apr 2026 7 Jul 2026
AmbioPharmCASE #VI-2026-0177 A 2 10.0 10.0 10.0 7 May 2026 17 May 2026
HomopeptideCASE #VI-2026-0760 A 7 9.9 9.9 10.0 24 May 2026 24 May 2026
BachemCASE #VI-2026-0314 A 4 9.9 9.9 10.0 2 Feb 2026 7 Jul 2026
PolyPeptide GroupCASE #VI-2026-0143 A 4 9.9 9.9 10.0 11 May 2026 26 Jul 2026
Shanghai Wibson BiotechnologyCASE #VI-2026-0379 A 3 9.9 9.9 9.9 11 Apr 2026 7 Jun 2026
Thermo Fisher ScientificCASE #VI-2026-0142 A 3 9.9 9.9 10.0 5 May 2026 28 Jul 2026
SinoPepCASE #VI-2026-0387 A 3 9.9 9.9 10.0 27 Mar 2026 28 Jun 2026
Flourishglobal PeptideCASE #VI-2026-0630 A 2 9.9 9.9 10.0 20 Apr 2026 5 Jul 2026
Shanghai Sigma AudleyCASE #VI-2026-0505 A 2 9.9 9.9 10.0 7 Apr 2026 17 May 2026
Hybio PharmaceuticalCASE #VI-2026-0065 A 2 9.9 9.9 10.0 19 May 2026 16 Jun 2026
Sigma-AldrichCASE #VI-2026-0829 A 2 9.9 9.9 10.0 10 Jun 2026 28 Jun 2026
Qingdao Sigma Chemical QSCCASE #VI-2026-0538 A 2 9.2 8.8 9.6 25 May 2026 25 May 2026
Wuhan Wansheng Bio (WWB)CASE #VI-2026-0594 A 5 8.8 7.6 10.0 21 May 2026 21 May 2026
Nantong Guangyuan Chemical GYCCASE #VI-2026-0284 A 2 8.7 8.0 9.4 25 May 2026 25 May 2026
Shanghai Sigma Audley SSACASE #VI-2026-0486 A 8 8.4 6.6 10.0 24 May 2026 24 May 2026
Glbiochem (Shanghai)CASE #VI-2026-0704 A 5 8.2 7.5 9.0 25 May 2026 25 May 2026
Yongkang Nuoao Trading CoCASE #VI-2026-0646 X 1 7.9 7.9 7.9 2 Apr 2025 2 Apr 2025
PeptidologyCASE #VI-2026-0520 X 1 7.6 7.6 7.6 9 Jun 2025 9 Jun 2025
Reta-PeptideCASE #VI-2026-0756 X 12 7.1 5.2 10.0 21 May 2025 20 May 2026
Heman Peptide HMCASE #VI-2026-0089 X 1 6.3 6.3 6.3 3 Jul 2025 3 Jul 2025
Polaris PeptidesCASE #VI-2026-0839 X 2 5.8 4.3 7.3 7 May 2025 25 May 2026
Explicit SarmsCASE #VI-2026-0017 X 1 0.0 0.0 0.0 3 Jul 2025 3 Jul 2025

Open any subject to view the batch-level evidence for Tren Hex Raw alone.